Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Lupus|February 24, 2001
Safety profile and causes of withdrawal due to adverse events in systemic lupus erythematosus patients treated long-term with cyclosporine AF Conti, R Priori, C Alessandri, et al.
Reumatismo|October 24, 2015
Joint involvement in patients affected by systemic lupus erythematosus: application of the swollen to tender joint count ratioE Cipriano, F Ceccarelli, L Massaro, et al.
Annals of the Rheumatic Diseases|July 16, 2002
Anti-tumour necrosis factor (TNF) alpha treatment of rheumatoid arthritis (infliximab) selectively down regulates the production of interleukin (IL) 18 but not of IL12 and IL13V Pittoni, M Bombardieri, F R Spinelli, et al.
Reumatismo|January 31, 2020
Gender equality in RheumatologyS L Bosello, M S Chimenti, P Conigliaro, et al.
Reumatismo|March 25, 2024
Evaluation of diagnostic and therapeutic delay in patients with rheumatoid arthritis and psoriatic arthritisM Iacovantuono, S Ferrigno, P Conigliaro, et al.
La Clinica Terapeutica|November 13, 2013
Biological therapies in rheumatic diseasesF Conti, F Ceccarelli, L Massaro, et al.
Reumatismo|June 19, 2014
Pain and systemic lupus erythematosusM Di Franco, M P Guzzo, F R Spinelli, et al.
Reumatismo|July 28, 2009
Switching between TNFalpha antagonists in rheumatoid arthritis: personal experience and review of the literatureR Scrivo, F Conti, F R Spinelli, et al.
Food Chemistry|October 17, 2013
Phenolic composition and antioxidant activity in sparkling wines: modulation by the ageing on leesC A Stefenon, C De M Bonesi, V Marzarotto, et al.
Lupus|March 26, 2019
CD44v3 and CD44v6 isoforms on T cells are able to discriminate different disease activity degrees and phenotypes in systemic lupus erythematosus patientsL Novelli, C Barbati, F Ceccarelli, et al.
Pageof 3